Patent: 9,821,114
✉ Email this page to a colleague
Summary for Patent: 9,821,114
Title: | Compartmentalized method of nucleic acid delivery and compositions and uses thereof |
Abstract: | Provided herein is a method of delivering nucleic acid molecules to a compartmentalized tissue or organ of a subject. Also provided herein are uses and processes for delivering a nucleic acid molecule to the parenchyma of a compartmentalized tissue or organ. The methods and uses can be used in the treatment of diseases and conditions and in industrial, agricultural and veterinary applications. Also provided herein are compositions containing an adenovirus or adeno-associated virus or other recombinant virus formulated for administration to the parenchyma of a tissue or organ. |
Inventor(s): | Cabrera Aquino; Jose Gustavo (Mexico City, MX), Segura Pacheco; Blanca Angelica (Mexico City, MX) |
Assignee: | Global Bio Therapeutics, Inc. (San Diego, CA) |
Application Number: | 13/815,206 |
Patent Claims: | see list of patent claims |
Details for Patent 9,821,114
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genzyme Corporation | CEREZYME | imiglucerase | For Injection | 020367 | 05/23/1994 | ⤷ Try a Trial | 2032-02-07 |
Genzyme Corporation | CEREZYME | imiglucerase | For Injection | 020367 | 09/22/1999 | ⤷ Try a Trial | 2032-02-07 |
Microbix Biosystems Inc. | KINLYTIC | urokinase | For Injection | 021846 | 01/16/1978 | ⤷ Try a Trial | 2032-02-07 |
Biomarin Pharmaceutical Inc. | ALDURAZYME | laronidase | Injection | 125058 | 04/30/2003 | ⤷ Try a Trial | 2032-02-07 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |